Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
Where this comes from
- Record sourced from PubMed, PMID 32291416.
- Also identified by DOI 10.1038/s41591-020-0864-x and PMC identifier 7819238.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.